phenylalanine has been researched along with Narcolepsy in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 15 (68.18) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Baladi, M; Bron, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ; Weaver, TE | 1 |
| Babson, K; Benca, RM; Bujanover, S; Krystal, AD; Lee, L; Malhotra, A; Rosenberg, R; Schweitzer, PK; Strohl, KP | 1 |
| Carter, LP; Chen, D; Lammers, GJ; Overeem, S; Ramaekers, JG; Vermeeren, A; Vinckenbosch, F; Wang, G; Zhou, K | 1 |
| Ahmed, M; Baladi, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ | 1 |
| Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, HA; Lammers, GJ; Lee, L; Mayer, G; Menno, D; Plazzi, G; Shapiro, CM; Thorpy, MJ; Villa, KF | 1 |
| Garland, S; Piszczatoski, C; Powell, J | 1 |
| Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, H; Lammers, GJ; Lee, L; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ | 1 |
| Lou, G; Wang, T; Xu, Q; Zhang, L | 1 |
| Jha, D; K C, B; Ray, BK; Singh, R; Subedi, R; Thakur, RK | 1 |
| Baladi, M; Bron, M; Rosenberg, R | 1 |
| Bron, M; Crosby, RD; Mathias, SD; Menno, DM; Morris, S; Weaver, TE | 1 |
| Chen, G; Gao, H; Li, X; Wang, J; Wang, T; Xu, X; Xu, Z; Yang, S | 1 |
| Cavalli, F; Franceschini, C; Pizza, F; Plazzi, G | 1 |
| Bujanover, S; Dauvilliers, Y; Gotfried, M; Malhotra, A; Rosenberg, R; Scheckner, B; Schweitzer, PK; Thorpy, MJ; Zammit, G | 1 |
| Belliard, S; Berrebi-Bertrand, I; Finance, O; Giret, M; Krief, S; Lecomte, JM; Ligneau, X; Nagmar, I; Perrin, D; Robert, P; Schwartz, JC; Uguen, M | 1 |
| Black, J; Bogan, RK; Bream, G; Carter, LP; Emsellem, H; Feldman, N; Khayrallah, M; Lankford, A; Lu, Y; Ruoff, C | 1 |
| Becker, PM; Black, J; Bream, G; Emsellem, HA; Khayrallah, M; Lankford, A; Lu, Y; Ruoff, C; Scrima, L | 1 |
| Black, J; Carter, LP; Chen, D; Corser, BC; Dauvilliers, Y; Emsellem, H; Lu, Y; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ; Wang, H | 1 |
| Gao, J; Yang, J | 1 |
| Bogan, RK; Bream, G; Emsellem, HA; Feldman, N; Khayrallah, M; Lankford, DA; Lu, Y; Rosenberg, R | 1 |
| Black, J; Bream, G; Doekel, R; Emsellem, HA; Feldman, NT; Khayrallah, MA; Lu, Y; Rosenberg, R; Ruoff, C; Swick, TJ | 1 |
| Buxton, BH; Curzon, G; Fenton, G; Kantamaneni, BD; Parkes, JD; Record, C; Struthers, G | 1 |
6 review(s) available for phenylalanine and Narcolepsy
| Article | Year |
|---|---|
Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
Topics: Carbamates; Clinical Trials as Topic; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents | 2020 |
[Advances in treatment of narcolepsy].
Topics: Carbamates; Cataplexy; Drug Development; Humans; Narcolepsy; Phenylalanine; Piperidines | 2020 |
Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive | 2020 |
Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Sleepiness | 2021 |
A practical guide to the pharmacological and behavioral therapy of Narcolepsy.
Topics: Behavior Therapy; Carbamates; Counseling; Humans; Modafinil; Narcolepsy; Phenylalanine; Piperidines; Wakefulness-Promoting Agents | 2021 |
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy.
Topics: Adrenergic Uptake Inhibitors; Animals; Carbamates; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Humans; Narcolepsy; Phenylalanine; Treatment Outcome | 2019 |
12 trial(s) available for phenylalanine and Narcolepsy
| Article | Year |
|---|---|
Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
Topics: Carbamates; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome | 2022 |
Effects of solriamfetol on on-the-road driving in participants with narcolepsy: A randomised crossover trial.
Topics: Adult; Automobile Driving; Carbamates; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine | 2023 |
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
Topics: Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome | 2020 |
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Efficiency; Female; Humans; Male; Narcolepsy; Phenylalanine; Physical Functional Performance; Quality of Life; Surveys and Questionnaires; Wakefulness | 2020 |
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
Topics: Adult; Carbamates; Cataplexy; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine; Treatment Outcome; Wakefulness | 2020 |
Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.
Topics: Adolescent; Adult; Aged; Carbamates; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2021 |
Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Incidence; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Treatment Outcome | 2022 |
Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes.
Topics: Adult; Carbamates; Cross-Over Studies; Female; Humans; Male; Narcolepsy; Phenylalanine; Sleep; Time Factors; Treatment Outcome; Wakefulness; Wakefulness-Promoting Agents | 2017 |
Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110.
Topics: Adult; Area Under Curve; Carbamates; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine; ROC Curve; Severity of Illness Index; Treatment Outcome; Wakefulness-Promoting Agents | 2017 |
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
Topics: Adult; Carbamates; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Latency; Sleepiness; Treatment Outcome; Wakefulness-Promoting Agents; Young Adult | 2019 |
Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Treatment Outcome; Wakefulness | 2015 |
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
Topics: Adult; Aged; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Stages; Treatment Outcome; Wakefulness; Wakefulness-Promoting Agents | 2016 |
4 other study(ies) available for phenylalanine and Narcolepsy
| Article | Year |
|---|---|
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Quality of Life; Sleep Apnea, Obstructive | 2021 |
Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive | 2021 |
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corpus Striatum; Disorders of Excessive Somnolence; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Drug Inverse Agonism; Feeding Behavior; Histamine Antagonists; Locomotion; Mice; Modafinil; Narcolepsy; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Phenylalanine; Piperidines; Receptors, Histamine H3; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents | 2021 |
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings.
Topics: Adult; Amphetamine; Aspartic Acid; Body Weight; Cataplexy; Cerebrospinal Fluid Proteins; Dextroamphetamine; Electroencephalography; Feeding and Eating Disorders; Female; Homovanillic Acid; Humans; Libido; Male; Mental Disorders; Methionine; Middle Aged; Narcolepsy; Phenylalanine; Syndrome; Tyrosine | 1974 |